Association Between Adequate Serum 25(OH)D Levels and Atherogenic Dyslipidemia in Young Adults
-
Published:2023
Issue:
Volume:
Page:
-
ISSN:1340-3478
-
Container-title:Journal of Atherosclerosis and Thrombosis
-
language:en
-
Short-container-title:JAT
Author:
Chen Ching-Way1, Han Yin-Yi2, Hwang Jing-Shiang3, Rizzo Manfredi4, Yamashita Shizuya5, Hsu Sandy Huey-Jen6, Su Ta-Chen7
Affiliation:
1. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine 2. Department of Anesthesiology, National Taiwan University Hospital 3. Institute of Statistical Science, Academia Sinica 4. Department of Internal Medicine and Medical Specialties (DIMIS), Università degli Studi di Palermo UNIPA 5. Department of Cardiology, Rinku General Medical Center 6. Department of Laboratory Medicine, College of Medicine, National Taiwan University Hospital, National Taiwan University 7. Department of Environmental and Occupational Medicine, National Taiwan University Hospital
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Reference45 articles.
1. 1) Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Ärnlöv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Bärnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catalá-López F, Choi JY, Christensen H, Cirillo M, Cooper L, Jr., Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M and Murray C: Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol, 2017; 70: 1-25 2. 2) Berberich AJ and Hegele RA: A Modern Approach to Dyslipidemia. Endocrine Reviews, 2021; 43: 611-653 3. 3) Ferrieres J, Bongard V, Arveiler D, Dallongeville J, Wagner A, Amouyel P, Valensi P and Ruidavets JB: Long-term impact on mortality of residual dyslipidemia. European Heart Journal, 2013; 34: 4. 4) Xiao C, Dash S, Morgantini C, Hegele RA and Lewis GF: Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes, 2016; 65: 1767-1778 5. 5) Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I and Yamamoto TT: The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb, 2004; 11: 200-208
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|